Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Fundamental medical mycology [[electronic resource] /] / Errol Reiss, H. Jean Shadomy, G. Marshall Lyon III
| Fundamental medical mycology [[electronic resource] /] / Errol Reiss, H. Jean Shadomy, G. Marshall Lyon III |
| Autore | Reiss Errol |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Blackwell, c2012 |
| Descrizione fisica | 1 online resource (655 p.) |
| Disciplina | 616.9/6901 |
| Altri autori (Persone) |
ShadomyH. Jean
LyonG. Marshall |
| Soggetto topico |
Medical mycology
Microbiology |
| ISBN |
1-283-28271-2
9786613282712 1-118-10176-6 1-118-10177-4 1-118-10175-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Fundamental Medical Mycology; Fundamental Medical Mycology; Contents; Contents; Preface; Acknowledgments; Part One Introduction to Fundamental Medical Mycology, Laboratory Diagnostic Methods, and Antifungal Therapy; 1. Introduction to Fundamental Medical Mycology; 1.1 Topics not Covered, or Receiving Secondary Emphasis; 1.2 Biosafety Considerations: Before You Begin Work with Pathogenic Fungi...; 1.2.1 Biological Safety Cabinets (BSC); 1.2.2 Precautions to Take in Handling Etiologic Agents that Cause Systemic Mycoses; 1.2.3 Additional Precautions at Biosafety Level 3 (BSL 3)
1.2.4 Safety Training1.2.5 Disinfectants and Waste Disposal; 1.3 Fungi Defined: Their Ecologic Niche; 1.4 Medical Mycology; 1.5 A Brief History of Medical Mycology; 1.5.1 Ancient Greece; 1.5.2 Middle Ages; 1.5.3 Twentieth Century; 1.5.4 Endemic Mycoses in the Americas; 1.5.5 Era of Immunosuppression in the Treatment of Cancer, Maintenance of Organ Transplants, and Autoimmune Diseases; 1.5.6 Opportunistic Mycoses; 1.5.7 HIV/AIDS; 1.5.8 Twenty-first Century; 1.6 Rationale for Fungal Identification; 1.6.1 Developing the Treatment Plan; 1.6.2 Investigating Outbreaks 1.6.3 Determining the Susceptibility to Antifungal Agents1.6.4 Estimating the Significance of Fungi Generally Considered to be Opportunists or Saprobes; 1.6.5 Types of Vegetative Growth; 1.7 Sporulation; 1.8 Dimorphism; 1.8.1 Dimorphism and Pathogenesis; 1.9 Sex in Fungi; 1.9.1 Anamorph and Teleomorph Nomenclature; 1.10 Classification of Mycoses Based on the Primary Site of Pathology; 1.10.1 Superficial Mycoses; 1.10.2 Cutaneous Mycoses; 1.10.3 Systemic Opportunistic Mycoses; 1.10.4 Subcutaneous Mycoses; 1.10.5 Endemic Mycoses Caused by Dimorphic Environmental Molds 1.11 Taxonomy/Classification: Kingdom Fungi1.11.1 The Phylogenetic Species Concept for Classification; 1.11.2 The Higher Level Classification of Kingdom Fungi; 1.12 General Composition of the Fungal Cell; 1.12.1 Yeast Cell Cycle; 1.12.2 Hyphal Morphogenesis; 1.12.3 Cell Wall; 1.13 Primary Pathogens; 1.13.1 Susceptibility to Primary Pathogens; 1.14 Endemic Versus Worldwide Presence; 1.15 Opportunistic Fungal Pathogens; 1.15.1 Susceptibility to Opportunistic Fungal Pathogens: Host Factors; 1.16 Determinants of Pathogenicity; General References in Medical Mycology Selected References for Introduction to Fundamental Medical MycologyWebsites Cited; Questions; 2. Laboratory Diagnostic Methods in Medical Mycology; 2.1 Who Is Responsible for Identifying Pathogenic Fungi?; 2.1.1 Role of the Clinical Laboratorian; 2.1.2 Role of the Physician; 2.2 What Methods are Used to Identify Pathogenic Fungi?; 2.2.1 Culture and Identification; 2.3 Laboratory Detection, Recovery, and Identification of Fungi in the Clinical Microbiology Laboratory; 2.3.1 The Laboratory Manual; 2.3.2 Specimen Collection; 2.3.3 Direct Examination; 2.3.4 Histopathology; 2.3.5 Culture 2.3.6 Storage and Cryopreservation of Cultures for QA and QC in the Clinical Mycology Laboratory |
| Record Nr. | UNINA-9910141246603321 |
Reiss Errol
|
||
| Hoboken, N.J., : Wiley-Blackwell, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fundamental medical mycology [[electronic resource] /] / Errol Reiss, H. Jean Shadomy, G. Marshall Lyon III
| Fundamental medical mycology [[electronic resource] /] / Errol Reiss, H. Jean Shadomy, G. Marshall Lyon III |
| Autore | Reiss Errol |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley-Blackwell, c2012 |
| Descrizione fisica | 1 online resource (655 p.) |
| Disciplina | 616.9/6901 |
| Altri autori (Persone) |
ShadomyH. Jean
LyonG. Marshall |
| Soggetto topico |
Medical mycology
Microbiology |
| ISBN |
1-283-28271-2
9786613282712 1-118-10176-6 1-118-10177-4 1-118-10175-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Fundamental Medical Mycology; Fundamental Medical Mycology; Contents; Contents; Preface; Acknowledgments; Part One Introduction to Fundamental Medical Mycology, Laboratory Diagnostic Methods, and Antifungal Therapy; 1. Introduction to Fundamental Medical Mycology; 1.1 Topics not Covered, or Receiving Secondary Emphasis; 1.2 Biosafety Considerations: Before You Begin Work with Pathogenic Fungi...; 1.2.1 Biological Safety Cabinets (BSC); 1.2.2 Precautions to Take in Handling Etiologic Agents that Cause Systemic Mycoses; 1.2.3 Additional Precautions at Biosafety Level 3 (BSL 3)
1.2.4 Safety Training1.2.5 Disinfectants and Waste Disposal; 1.3 Fungi Defined: Their Ecologic Niche; 1.4 Medical Mycology; 1.5 A Brief History of Medical Mycology; 1.5.1 Ancient Greece; 1.5.2 Middle Ages; 1.5.3 Twentieth Century; 1.5.4 Endemic Mycoses in the Americas; 1.5.5 Era of Immunosuppression in the Treatment of Cancer, Maintenance of Organ Transplants, and Autoimmune Diseases; 1.5.6 Opportunistic Mycoses; 1.5.7 HIV/AIDS; 1.5.8 Twenty-first Century; 1.6 Rationale for Fungal Identification; 1.6.1 Developing the Treatment Plan; 1.6.2 Investigating Outbreaks 1.6.3 Determining the Susceptibility to Antifungal Agents1.6.4 Estimating the Significance of Fungi Generally Considered to be Opportunists or Saprobes; 1.6.5 Types of Vegetative Growth; 1.7 Sporulation; 1.8 Dimorphism; 1.8.1 Dimorphism and Pathogenesis; 1.9 Sex in Fungi; 1.9.1 Anamorph and Teleomorph Nomenclature; 1.10 Classification of Mycoses Based on the Primary Site of Pathology; 1.10.1 Superficial Mycoses; 1.10.2 Cutaneous Mycoses; 1.10.3 Systemic Opportunistic Mycoses; 1.10.4 Subcutaneous Mycoses; 1.10.5 Endemic Mycoses Caused by Dimorphic Environmental Molds 1.11 Taxonomy/Classification: Kingdom Fungi1.11.1 The Phylogenetic Species Concept for Classification; 1.11.2 The Higher Level Classification of Kingdom Fungi; 1.12 General Composition of the Fungal Cell; 1.12.1 Yeast Cell Cycle; 1.12.2 Hyphal Morphogenesis; 1.12.3 Cell Wall; 1.13 Primary Pathogens; 1.13.1 Susceptibility to Primary Pathogens; 1.14 Endemic Versus Worldwide Presence; 1.15 Opportunistic Fungal Pathogens; 1.15.1 Susceptibility to Opportunistic Fungal Pathogens: Host Factors; 1.16 Determinants of Pathogenicity; General References in Medical Mycology Selected References for Introduction to Fundamental Medical MycologyWebsites Cited; Questions; 2. Laboratory Diagnostic Methods in Medical Mycology; 2.1 Who Is Responsible for Identifying Pathogenic Fungi?; 2.1.1 Role of the Clinical Laboratorian; 2.1.2 Role of the Physician; 2.2 What Methods are Used to Identify Pathogenic Fungi?; 2.2.1 Culture and Identification; 2.3 Laboratory Detection, Recovery, and Identification of Fungi in the Clinical Microbiology Laboratory; 2.3.1 The Laboratory Manual; 2.3.2 Specimen Collection; 2.3.3 Direct Examination; 2.3.4 Histopathology; 2.3.5 Culture 2.3.6 Storage and Cryopreservation of Cultures for QA and QC in the Clinical Mycology Laboratory |
| Record Nr. | UNINA-9910814256903321 |
|
Reiss Errol
|
||
| Hoboken, N.J., : Wiley-Blackwell, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||